Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New implant could curb heavy drinking for months

NCT ID NCT07433413

First seen Feb 28, 2026 · Last updated Jun 20, 2026 · Updated 18 times

Summary

This Phase 3 trial tests a naltrexone implant placed under the skin to help people with moderate to severe alcohol use disorder drink less. About 240 adults will receive either the implant or a placebo, plus counseling. Researchers will track heavy drinking days over 24 weeks to see if the implant works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER (AUD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

naltrexone hydrochloride implant

What this could lead to

If successful, this implant could provide a long-lasting treatment option to help people with alcohol use disorder reduce heavy drinking days.

What could go wrong

This is a Phase 3 trial, but it hasn't started recruiting yet. The implant may not work better than placebo, and side effects like nausea or implant site reactions are possible.

Conditions

The condition(s) this trial relates to.

alcohol abuse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.